Sustainable and tenable renal health model: A Latin American proposal of classification, programming, and evaluation  by Calderón, Rafael Burgos & Depine, Santos
Kidney International, Vol. 68, Supplement 97 (2005), pp. S23–S30
Sustainable and tenable renal health model: A Latin American
proposal of classification, programming, and evaluation
RAFAEL BURGOS CALDERO´N and SANTOS DEPINE
Section of Nephrology, Department of Medicine, University of Puerto Rico, School of Medicine, San Juan, Puerto Rico; Special
Program Administration, Ministry of Health, Buenos Aires, Argentina
Sustainable and tenable renal health model: A Latin American
proposal of classification, programming, and evaluation.
Background. End-stage renal disease (ESRD) presents a ma-
jor problem to public health, with complex implications for
social and economic structures in every nation of the world.
Clearly, Latin American and Caribbean countries are not able
to meet the needs of every patient requiring dialysis treatment
at ESRD. Consequently, a considerable number of patients die
every year as a result of lack of resources. Aware of this se-
rious social, ethical, and economic problem, the Latin Ameri-
can Society of Nephrology and Hypertension proposed a new
renal health concept in the region. In December 2002, at the
workshop in Valdivia, Chile, a modification to the National Kid-
ney Foundation Classification of Chronic Kidney Disease was
approved.
Project. According to modifications to the concept of chronic
kidney disease approved in the Declaration of Valdivia, a new
Renal Health Model was proposed. It consists of including or-
derly follow-up in patients’ charts, starting from the earliest
stage, and a model establishing a guideline for the reallocation
of financial resources to guarantee continuity of treatment to
patients with ESRD.
Conclusion. The implementation of the Renal Health Pro-
gram in health ministries of Latin American and Caribbean
countries would allow for a substantial improvement in renal
health prevention and management, as a result of better distri-
bution of financial and human resources.
Un modelo sustentable de salud renal: La propuesta Lati-
noamericana de evaluacio´n y clasificacio´n de la enfermedad
renal.
Antecedentes. La insuficiencia renal cro´nica (IRC) representa
un serio problema de salud pu´blica, con serias implicaciones
para las estructuras sociales y econo´micas de cada nacio´n en
el mundo. Es evidente que los paı´ses Latinoamericanos y del
Caribe no tienen la capacidad de proporcionar tratamiento
dialı´tico a todo aquel paciente con IRC que lo solicite, por lo
que un nu´mero importante de ellos mueren cada an˜o por falta
de este recurso. Conciente de las implicaciones e´ticas, sociales
y econo´micas que lo anterior significa, la Sociedad Latinoamer-
icana de Nefrologı´a e Hipertensio´n (SLANH) ha propuesto un
nuevo concepto de Salud Renal en la regio´n. En Diciembre del
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2002, en la ciudad de Valdivia, Chile, se aprobaron las modifi-
caciones a la Clasificacio´n de las Enfermedades Renales de la
National Kidney Foundation.
Proyecto. Las modificaciones aprobadas en la Declaracio´n de
Valdivia establecen un nuevo modelo de salud renal. Consisten
en la inclusio´n de gra´ficos del seguimiento ordenado de los pa-
cientes, iniciando desde las etapas iniciales de la IRC ası´ como
un modelo que establece la guı´a para la reasignacio´n de recur-
sos econo´micos que garanticen la continuidad del tratamiento
del enfermo renal cro´nico.
Conclusion. La aplicacio´n del Modelo de Salud Renal por
los Ministerios de Salud de las naciones Latinoamericanas y
del Caribe, podrı´a resultar en una mejora sustancial en la pre-
vencio´n y manejo de la IRC como resultado de una mejor dis-
tribucio´n de los recursos humanos y econo´micos.
End-stage renal disease (ESRD) represents a major
problem for public health, and it brings about complex
implications to social and economic structures of every
nation in the world. Currently, an estimated 1,100,000
patients are receiving dialysis treatment worldwide at a
compound cost of US $72 billion. By 2010, it is estimated
that over 2,000,000 people will have started dialysis at
a compound annual cost of US $1.1 trillion [1]. In the
United States, there are over 320,000 patients in dialy-
sis, and it is expected that by 2010 this figure will rise to
650,000 at a cost of US $25 billion [2].
By 1999, there were 107,953 patients receiving dialysis
treatment in 17 Latin American and Caribbean nations,
an average rate of 240 patients per million inhabitants, at
a cost of US $1.5 billion. The cost of dialysis was equiv-
alent to US $3.22 per inhabitant. If we compare those
figures with the rate of patients in dialysis in countries
with a more comprehensive health insurance, like the
United States, it can be assumed that some 200,000 to
500,000 patients in our region do not receive adequate
treatment [3]. For both developed and developing coun-
tries, dialysis treatment represents a serious ethical and
economic issue, because it is related to the macrodistribu-
tion of scarce resources in modern societies. Assuredly,
in Latin American and Caribbean countries, not all pa-
tients requiring dialysis can receive treatment, and thus a
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considerable number of patients die every year as a result
of lack of resources.
Aware of this serious social, ethical, and economic
problem, in 1997 the Latin American Society of Nephrol-
ogy and Hypertension approved a renal health concept
for the region. The new concept, which is based on health
promotion, emphasizes the close relationship between
healthy practices, risks, and prevalent community health
indicators. With this model, the term “renal health”
changes the focus of intervention in renal diseases and
establishes adequate strategies that are included within
the concept of positive health. In turn, these strategies
bind the biomedical models to a socioecologic paradigm
of health that includes primary, secondary, and tertiary
prevention.
In February 2002, the National Kidney Foundation es-
tablished chronic kidney disease as a major public health
issue, especially in the United States, where it represents
a high-cost condition with a poor outcome. To that effect,
the term “chronic kidney disease” was defined, and a clas-
sification based on the calculation of the glomerular fil-
tration rate (GFR) in 5 different stages was proposed [4].
This classification constitutes an important step toward
establishing a common language among different stake-
holders in the renal field. It also provides an extremely
useful tool to establish therapeutic protocols adequate
enough to reduce the progression of renal diseases. The
National Kidney Foundation also emphasizes the impor-
tance of early detection of albuminuria, hypertension,
and other comorbid conditions associated with chronic
kidney disease.
In December 2002, a workshop called “Towards a
Sustainable and Sustentable Renal Health Model” was
held in Valdivia, Chile, which was sponsored by the
Pan-American Health Organization, the Latin Ameri-
can Society of Nephrology and Hypertension, the Austral
University of Chile, and the Chilean Society of Nephrol-
ogy. The Declaration of Valdivia was approved on that
occasion, the highlights of which are hereby presented:
Latin America and the Caribbean are in the process of
developing new strategies to deal aggressively with pub-
lic health problems. In this context, ESRD represents a
real challenge because of the important socioeconomic
and ethical inequities observed in the region. Given the
difficulty in allocating sufficient economic resources to
provide for the needs of the indigent population, it is
mandatory to recognize the full implications of devel-
oping new strategies that allow for the provision of an
adequate coverage of renal health. Consequently, in or-
der to attend to the aforementioned problems, a Renal
Health Model that sets the basis of planning, program-
ming, execution, and evaluation of the program should
be adopted.
Accordingly, the following plan of action was proposed:
(1) Establishing a system of identification of patients, ac-
cording to evolutionary stages, in order to facilitate the
classification of Chronic Kidney Disease of the National
Kidney Foundation, with modifications proposed in the
Puerto Rico classification; (2) establishing a referral and
counter-referral system for an orderly movement of re-
nal patients at the primary health care level; (3) setting
targets and establishing therapeutic plans to facilitate the
use of flowcharts, diagnosis, and therapeutic algorithms;
and (4) integration of the Renal Health Model in the na-
tional public health policies of each country, using the
tools of the logical framework and the matrix of alloca-
tion of activities and resources.
At the workshop in Valdivia, Chile, the Subcommit-
tee of Renal Health of the Latin American Society
of Nephrology and Hypertension proposed a modifica-
tion of the National Kidney Foundation Classification
of Chronic Kidney Disease (Puerto Rico classification)
(Table 1). This modification consists of the inclusion of
the degree of hypertension using the classification of
blood pressure rates for adults aged 18 years and over
recommended in the Sixth Report of the Joint National
Committee on Prevention, Detection, Evaluation and
Treatment of High Blood Pressure. [5] A classification
of A to F is assigned to each grade of arterial blood pres-
sure. The proposed modification also includes a classi-
fication of 1 to 3 assigned to each level of albumin in
urine, which should be given according to recommended
definitions [6] (Table 1). Following the proposed classi-
fication, a 40-year-old man with a history of type 2 di-
abetes mellitus, GFR 50 cc/min, blood pressure 160/100
mm Hg, and albuminuria level 500 mg/24 h would be di-
agnosed with chronic kidney disease stage III, grade E,
level 3, secondary to type 2 diabetes mellitus. The mea-
surement of the GFR can be taken using the Cockcroft-
Gault [7], Modification of Diet in Renal Disease [8], or
Schwartz’s formulas [9]. Nevertheless, as indicated by
Coresh et al [10], the calibration of the serum creati-
nine assay is critical to avoid variation in serum creati-
nine value, which could prominently affect the results in
the higher GFR values. Harwell [11] and Hostetter [12]
have recently commented publicly on the existing bar-
riers of measuring serum creatinine and albuminuria in
the United States. These criticisms also apply to Latin
American and Caribbean countries.
The proposed modification enables a more accurate
follow-up and an objective evaluation of preset tar-
gets and objectives, which are accomplished by care-
fully using the matrix and follow-up chart. (Table 1). The
matrix includes stages of GFR, grade of blood pressure
control, and albuminuria to facilitate the systematization
of the follow-up of the mentioned variables; it is com-
plemented with a chart that includes main risk factors
related to the progression of chronic kidney disease and
cardiovascular complications in the patient. It is impor-
tant to add to the chart the therapeutic interventions
Caldero´n and Depine: A Sustainable and tenable renal health model S-25
Table 1. Matrix of classification, remission, and regression of chronic kidney disease follow-up and evaluation chart
prescribed on each control visit to obtain the best clin-
ical assessment for an accurate evaluation of the patient
with chronic kidney disease. It is also mandatory to adopt
the follow-up matrix if patients with diabetes, or at least
high-risk patients with diabetes, are to be treated with
angiotensin-converting enzyme inhibitors or angiotensin
receptor blockers, without previous screening for albu-
min in urine [13, 14]. Hostetter [12] has recently expressed
that prophylactic treatment without previous screening
can only be successful when GFR and blood pressure are
monitored regularly.
Although the proposed classification of chronic kidney
disease provides a better understanding of the indica-
tors and important variables in each patient with chronic
kidney disease, the ultimate goal is to obtain regression
of the disease with remission and regression of protein-
uria. Ruggenenti et al [15] have proposed certain vari-
ables with their respective ranges, which could be used to
evaluate the above-mentioned parameters. Follow-up of
these patients should be orderly and well planned. The
target is not only to obtain a correct classification of each
patient but to provide evidence that expected progression
and regression of chronic kidney disease is achieved, and
that there is adequate management of the comorbidities
associated with chronic kidney disease.
SUSTAINABLE AND TENABLE RENAL
HEALTH MODEL
The lack of simultaneous and coordinated strategies
for the treatment of patients with renal disease has caused
countries to spend excessively and inefficiently in the re-
nal health disease process. In addition, the exponential
growth of patients who will require dialysis or transplan-
tation in the future demands an increase in the provi-
sion of funds. This situation has become a major concern
worldwide for those in charge of the allocation of eco-
nomic resources, especially in developing countries.
Our proposal offers a viable answer to the problem
through implementation of the Renal Health Model,
which has been programmed and developed to incorpo-
rate the ethics of team management at the primary health
care level and the ethics concerning allocation of those
resources.
Given that models are conceptual entities designed on
a global, theoretical basis, each country has to provide its
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Fig. 1. Renal health model/program. Con-
ceptual entities.
own tools according to its culture, ideology, requirements,
and possibilities (Fig. 1).
The model favors work systematization, starting
with professional training focused on evidence-based
medicine applied to diagnosis, identification, and follow-
up of renal patients through the 5 stages of evolution until
dialysis treatment. The available information will allow
a satisfactory achievement of preset objectives and an
adequate distribution of financial and human resources.
This model also provides us with tools to check the de-
velopment of the program in order to make necessary
adjustments to meet goals and objectives.
Thus, the framework model includes coordinated
strategies such as strengthening of transplantation pro-
grams, improved mechanisms for resource allocation, pri-
vate and public assistance networks, permanent training
and education for specialized teams dealing particularly
with the primary health care level, suitable referral and
count referral systems, and systems of information and
data analysis that will enable continuous evaluation of
the patient and cause of the disease. These control sys-
tems will contribute to the elaboration of actuarial con-
structs for the provision of resources to cover demands
of dialysis treatment or transplantation, according to the
expected number of patients entering end-stage kidney
disease (Fig. 2).
Implementation of this model, which will have to be
adjusted to the particular needs of each country, will re-
sult in a reallocation of resources that are currently used
for the treatment of comorbidities associated with kidney
disease; these comorbidities are not dealt with compre-
hensively in the stages prior to dialysis or transplantation.
The Renal Health Model shows a systematic develop-
ment of the program, and its strategies and/or compo-
nents constitute its axial guidelines.
A first strategy consists of a proposal to generate a spe-
cial fund and/or to make budget reallocations into funds
for high complexity to ensure financial resources to de-
velop programs of identification and follow-up of renal
patients, or to guarantee continuity to dialysis treatments.
In countries with single funds for high-complexity dis-
eases, there is often budgetary infighting, which results in
the allocation of resources according to pressure exerted
either from medical groups or from patients’ associations.
We encourage budget reallocations, specially assigned to
dialysis treatments, to guarantee continuity of treatment
to patients with ESRD.
A second strategy consists of the development of com-
ponents to foster the strengthening of transplantation
programs and/or favoring of implementation of such pro-
grams in countries where transplantation has not yet de-
veloped as a common practice.
A third strategy is related to the health care provider
sector and consists of the integration of public and private
sectors to favor and/or strengthen network assistance in
the primary stage of renal health care.
A fourth strategy consists of the specific develop-
ment of a Renal Health Program, incorporating the
concept of “renal health control,” which articulates
the following subcomponents: Renal disease promo-
tion, tending to full participation of the nephrology
health care team in community strategies and pro-
grams such as Healthy Municipalities and Communi-
ties and/or Conjunto de Acciones para la Reduccio´n
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Fig. 2. Renal health model. Strategic development.
Multifactorial de las Enfermaded No Transmisibles/
Countrywide Integrated Non-Communicable Diseases
Intervention (CARMEN/CINDI) programs; renal dis-
ease prevention, focusing mainly on secondary preven-
tion. The systematization of the referral and counter
referral system that aims at achieving specific targets of
regression and/or remission of the disease takes place at
this stage. Aggressive treatment at this time in the course
of the disease is particularly important. In this work, we
define secondary prevention as the period during which
natural evolution of the disease occurs until the presen-
tation of end-stage renal failure, and tertiary prevention
to the treatment of comorbidities and complications re-
lated to dialysis and transplantation. The cost-efficiency
impact of the strategies applied at second- and third-
stage prevention has been mentioned in several publi-
cations on the subject. In a collaborative work, Rodby
et al [16] conducted a study on the total population of
patients with diabetes receiving dialysis in the United
States. As a result, it was estimated that a total savings
of US $2.4 billion in 10 years could have been made if
patients had been treated with captopril to slow the pro-
gression of renal disease. In addition, Caro and colleagues
[17] have demonstrated that after 30 years of treatment,
the total cost of the complications for each patient with
type 2 diabetes amounts to US $47,240; management
of renal disease: counseling patients as to whether they
should start dialysis treatment or not, according to the
principles of clinical ethics; Rehabilitation programs for
patients receiving dialysis treatment or transplantation;
research and teaching as essential components to achieve
the targets of the Renal Health Program.
A fifth strategy is to facilitate the assimilation, sharing,
and dissemination of information through implementa-
tion of operational circuits and databases.
Dismantling the first level of renal management as a re-
sult of regional programs for primary health care prevents
health and treasury ministries from acquiring important
knowledge about the unique aspects of renal disease, such
as the real demand of resources to deal with treatment
of the disease, best opportunities to gain access to treat-
ment, evaluation of quality standards, commitment and
training of human resources, assignment of facilities, and
best distribution of equipment and a quality control of
medical supplies. These public organizations also lack
adequate tools to draw up actuarial plans that will al-




It would not be feasible to present this proposal without
its corresponding program development, in order to allow
for the evaluation of outcomes concerning targets and
objectives and its resulting budgetary implementation.
To that effect, we have incorporated systematic, self-
assessing, matrix-related tools such as the logical frame-
work matrix [18], matrix of allocation of activities and
resources [19], matrix of classification, remission and
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Nonsustainable and tenable renal health model 
Fig. 3. Problems tree. The Problems tree represents a bunch of events that generate a nonsustainable renal health model.
regression of chronic kidney disease with its follow-up
chart previously described, and an operational annual
program.
To deal with the organization of the logical framework,
we have identified difficulties that result from the lack
of a renal health model, and we have expressed it as a
collection of events that make renal health assistance
nonsustainable. We have also identified the necessary
strategies required to make renal health assistance sus-
tainable and tenable. To the effect of presenting this work,
they will be referred to as “Problem Tree” and “Objec-
tives Tree,” respectively. They are the starting point of
the logical framework.
Our analysis emerges from 2 well-known variables: in-
creasing incidence of ESRD requiring dialysis treatment
and asymmetry in equity in an important portion of the
population of Latin America and the Caribbean. (Fig. 3)
The “Problem Tree” described previously represents
a collection of events that generates a nonsustain-
able model and an increased professional and commer-
cial risk. The origin of these consequences lies in an
inadequate funding of the sector, aggravated by prac-
tice of defensive medicine, absence of systematic train-
ing within a renal health model, and fragmented patient
attention which, evaluated by means of case-mix informa-
tion, lead to higher costs for medical attention at health
care centers. In addition, the public sector becomes over-
burdened as a result of the lack of public-private network
assistance and poor funding.
From the analysis of the “Problem Tree,” it can be
deduced that it is necessary to incorporate the follow-
ing items into the “Objectives Tree”: a specific pro-
gram of renal health, guaranteed funding, evidence-based
medical practice, public-private assistance networks, and
professional training components necessary to meet the
objectives of sustainability of the model, consequently
lowering professional and commercial risks and gaining
accessibility.
The “Objectives Tree” focuses on necessary strate-
gies needed to make renal health assistance sustainable
and tenable; that is, it concentrates centers on actual
needs rather than on the demand that reaches doctors
or institutions. (Fig. 4). The planning, programming, and
evaluation document, Logical Framework Matrix, takes
as verifiable indicators the percentage of renal health
primary care units proceeding and/or redirected from
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Fig. 4. Objectives tree. The Objectives tree
focuses on strategies needed to make renal
health assistance sustainable and tenable.
general medical practice, the percentage of trained or re-
trained professional staff, and budgetary disbursements
for the development of activities.
The Matrix for Allocation of Activities and Resources
is an instrument that enables a cost-efficient method of
distribution of activities and resources that are available
in each country, which avoids the possibility of wrong
budgetary assignments and allows for a more systematic
follow-up and assessment of results. It incorporates algo-
rithms based on medical evidence.
CONCLUSION
The Sustainable and Tenable Renal Health Model, by
means of its components and subcomponents, planning,
programming and evaluation program, method of classi-
fication, indicators of remission and regression of renal
disease, and other instruments linked to public health
attention, could become incorporated in programs of
health ministries as an invaluable tool that would allow
for a cost-efficient systematization of renal health man-
agement.
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